Developmental and Epileptic Encephalopathy clinical trials at UCSF

1 research study open to eligible people

Developmental and epileptic encephalopathy is a serious early brain disorder with frequent seizures and delayed skills. UCSF is testing new medicines in multicenter, double-blind, randomized, placebo-controlled studies for children and adults. UCSF is collecting seizure diaries, lab tests, and developmental assessments.

Showing trials for

  • LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

    open to eligible people ages 2-65

    This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DEE. The study consists of 3 main phases: Screening, Titration period, Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 24 months.

    San Francisco, California and other locations

Last updated: